Suppr超能文献

氯氮平起始治疗是否影响其他药物的合用?:来自印度的研究。

Does the Starting of Clozapine Influence Coprescription of Other Medications?: A Study From India.

机构信息

From the Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

J Clin Psychopharmacol. 2021;41(2):148-154. doi: 10.1097/JCP.0000000000001348.

Abstract

PURPOSE/BACKGROUND: Little is understood about the prescription load before and after the starting of clozapine. Accordingly, this study aimed to evaluate the medication load of patients receiving clozapine, just before starting clozapine and after being on clozapine for at least 1 year. Additionally, the impact of clozapine on severity of illness was evaluated.

METHODS/PROCEDURES: Two hundred seventy-seven outpatients receiving clozapine were prospectively evaluated for their prescription after at least 1 year of starting clozapine. Additionally, these patients were assessed on the Clinical Global Impression-Improvement scale to evaluate the overall clinical benefit with clozapine.

FINDINGS/RESULTS: They had been receiving clozapine for 6.55 (SD, 4.8; range, 1-24; median, 5) years at the time of assessment. At the start of clozapine, more than one third of the patients were receiving 2 antipsychotics. A small proportion was receiving other psychotropics, such as antidepressants, mood stabilizers, and benzodiazepines. After being on clozapine for 1 year, there was a significant reduction in the number of patients receiving two antipsychotic medications (P < 0.001), number of patients receiving antidepressants (if amitriptyline was left out), benzodiazepine (P < 0.001), and anticholinergic medications (P < 0.001). Further, there was a reduction in the mean chlorpromazine equivalent of antipsychotics (P < 0.001) and the total number of medications received by the patients (P < 0.001). However, there was an increase in the prescription rates of antihypertensive drugs (P = 0.03), anti-diabetic medications (P < 0.01), and anti-dyslipidemic medications. At follow-up, there was a significant improvement in symptoms as assessed by Clinical Global Impression-Improvement scale.

IMPLICATIONS/CONCLUSIONS: This study suggests that long-term use of clozapine is associated with substantial improvement in symptoms with a reduction in the medication load.

摘要

目的/背景:对于氯氮平开始使用前后的处方负荷,人们知之甚少。因此,本研究旨在评估至少接受氯氮平治疗 1 年后开始使用氯氮平的患者的药物负荷,并评估氯氮平对疾病严重程度的影响。

方法/程序:对 277 名接受氯氮平治疗的门诊患者进行前瞻性评估,以评估他们在开始接受氯氮平至少 1 年后的处方情况。此外,这些患者还接受了临床总体印象-改善量表的评估,以评估氯氮平的总体临床获益。

结果

在评估时,他们接受氯氮平治疗的时间为 6.55 年(SD,4.8;范围,1-24;中位数,5)。在开始使用氯氮平时,超过三分之一的患者正在服用 2 种抗精神病药物。少数患者正在服用其他精神药物,如抗抑郁药、情绪稳定剂和苯二氮䓬类药物。在使用氯氮平 1 年后,接受两种抗精神病药物治疗的患者数量显著减少(P < 0.001),接受抗抑郁药(如果排除阿米替林)、苯二氮䓬类药物(P < 0.001)和抗胆碱能药物治疗的患者数量减少(P < 0.001)。此外,抗精神病药物的氯丙嗪等效物平均值(P < 0.001)和患者接受的药物总数(P < 0.001)均有所减少。然而,抗高血压药物(P = 0.03)、抗糖尿病药物(P < 0.01)和抗血脂药物的处方率有所增加。在随访时,临床总体印象-改善量表评估显示症状显著改善。

意义/结论:本研究表明,长期使用氯氮平与症状的显著改善以及药物负荷的减少有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验